Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |